Orion
34.64 EUR +4.65%13,699 investors are following this company
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo.
P/E (24e)
22.02
EV/EBIT (adj.) (24e)
17.97
P/B (24e)
5.51
Dividend yield-% (24e)
4.76 %
Target price
42.00 EUR
Recommendation
Accumulate
Updated
13.2.2024
NASDAQ Helsinki
ORNBV
Daily low / high price
32.25 / 34.9
EUR
Market cap
4.89B EUR
Turnover
8.05M EUR
Volume
238K
Risk and recommendation
HighRiskLow
SellRecommendationBuy
Analyst
Antti Siltanen
Analyst
Latest videos
Financial calendar
Interim report
2024-04-25
Interim report
2024-08-08
Half year dividend
2024-10-15
Interim report
2024-10-29
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ilmarinen Mutual Pension Insurance Company | 3.7 % | 5.2 % |
Erkki Etola and companies | 2.0 % | 6.5 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Mikael Silvennoinen | 2023-11-15 | 44,782EUR |
Mikael Silvennoinen | 2023-11-15 | 27,034EUR |
Premium
This content is for our Premium customers only.
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 1,078.1 | 1,041.1 | 1,340.6 | 1,189.6 | 1,372.4 | 1,437.5 | 1,568.7 | 1,696.1 |
growth-% | 2.6 % | -3.4 % | 28.8 % | -11.3 % | 15.4 % | 4.7 % | 9.1 % | 8.1 % |
EBITDA | 336.5 | 289.0 | 486.6 | 326.4 | 331.0 | 360.5 | 427.1 | 492.4 |
EBIT (adj.) | 280.1 | 243.3 | 439.6 | 274.9 | 281.0 | 309.1 | 376.5 | 441.0 |
EBIT | 280.1 | 243.3 | 439.6 | 274.9 | 281.0 | 309.1 | 376.5 | 441.0 |
Profit before taxes | 278.3 | 242.3 | 440.3 | 271.9 | 279.8 | 303.1 | 370.6 | 435.6 |
Net income | 219.9 | 193.8 | 349.5 | 216.8 | 221.0 | 239.5 | 292.8 | 344.1 |
EPS (adj.) | 1.57 | 1.38 | 2.49 | 1.54 | 1.57 | 1.70 | 2.08 | 2.45 |
growth-% | 9.9 % | -11.9 % | 80.3 % | -38.0 % | 1.9 % | 8.4 % | 22.3 % | 17.5 % |
Dividend | 1.50 | 1.50 | 1.60 | 1.62 | 1.65 | 1.70 | 1.75 | 1.80 |
Dividend ratio | 95.8 % | 108.7 % | 64.3 % | 105.0 % | 104.9 % | 99.7 % | 84.0 % | 73.5 % |
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 31.2 % | 27.8 % | 36.3 % | 27.4 % | 24.1 % | 25.1 % | 27.2 % | 29.0 % |
EBIT-% (adj.) | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 20.5 % | 21.5 % | 24.0 % | 26.0 % |
EBIT-% | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 20.5 % | 21.5 % | 24.0 % | 26.0 % |
ROE | 29.1 % | 26.8 % | 43.1 % | 24.1 % | 24.9 % | 27.0 % | 31.9 % | 34.6 % |
ROI | 34.4 % | 29.5 % | 45.6 % | 24.9 % | 24.7 % | 25.9 % | 30.8 % | 34.6 % |
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 37.53 | 36.52 | 51.24 | 39.27 | 34.64 | 34.64 | 34.64 | 34.64 |
Shares | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 |
Market cap | 5,271.6 | 5,129.7 | 7,197.3 | 5,516.0 | 4,865.6 | 4,865.6 | 4,865.6 | 4,865.6 |
Enterprise value | 5,085.8 | 4,940.3 | 7,078.7 | 5,609.3 | 5,049.8 | 5,042.8 | 5,028.2 | 4,974.5 |
EV/S | 4.7 | 4.7 | 5.3 | 4.7 | 3.7 | 3.5 | 3.2 | 2.9 |
EV/EBITDA | 15.1 | 17.1 | 14.5 | 17.2 | 15.3 | 14.0 | 11.8 | 10.1 |
EV/EBIT (adj.) | 18.2 | 20.3 | 16.1 | 20.4 | 18.0 | 16.3 | 13.4 | 11.3 |
EV/EBIT | 18.2 | 20.3 | 16.1 | 20.4 | 18.0 | 16.3 | 13.4 | 11.3 |
P/E (adj.) | 24.0 | 26.5 | 20.6 | 25.4 | 22.0 | 20.3 | 16.6 | 14.1 |
P/E | 24.0 | 26.5 | 20.6 | 25.4 | 22.0 | 20.3 | 16.6 | 14.1 |
P/B | 7.2 | 7.2 | 7.9 | 6.2 | 5.5 | 5.5 | 5.1 | 4.7 |
P/S | 4.9 | 4.9 | 5.4 | 4.6 | 3.5 | 3.4 | 3.1 | 2.9 |
Dividend yield | 4.0 % | 4.1 % | 3.1 % | 4.1 % | 4.8 % | 4.9 % | 5.1 % | 5.2 % |
Equity ratio | 65.6 % | 66.0 % | 60.4 % | 61.9 % | 56.9 % | 56.9 % | 58.1 % | 61.6 % |
Gearing ratio | -25.4 % | -26.5 % | -13.1 % | 10.5 % | 20.8 % | 19.9 % | 17.2 % | 10.4 % |
Quarter data
Q1/23 | Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24e | Q2/24e | Q3/24e | Q4/24e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 277.9 | 289.6 | 301.0 | 321.1 | 1,189.6 | 306.2 | 321.3 | 311.8 | 433.1 |
EBITDA | 67.7 | 59.4 | 92.7 | 106.6 | 326.4 | 64.6 | 67.1 | 65.5 | 133.8 |
EBIT | 55.5 | 46.6 | 79.9 | 92.9 | 274.9 | 52.1 | 54.6 | 53.0 | 121.3 |
Profit before taxes | 55.1 | 45.8 | 78.5 | 92.5 | 271.9 | 51.8 | 54.3 | 52.7 | 121.0 |
Net income | 43.8 | 36.4 | 61.4 | 75.2 | 216.8 | 40.9 | 42.9 | 41.6 | 95.6 |
ShowingAll content types
Orion Group Interim Report January–March 2024
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools